Some breast cancers are well-known to overexpress different receptors including: estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth receptor 2 (HER2) (Eliyatkin et al., 2015). This evidence concerns the gene ERBB2 and breast carcinoma.